Certified by Founder Lodge
ATUM
United States - Newark, CA
INVESTOR
1 Disclosed Funding Rounds $21,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ATUM, formerly DNA2.0, offers an integrated pipeline of tools including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering and produ
| Company | Date | Round | Raised |
|---|---|---|---|
 Vernal Biosciences |
June, 02 ,2022 | Seed | $21,000,000 |
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
inKind | $450,000,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Zero Homes | $16,800,000 | (Feb 19, 2026)
